Wird geladen...
Theoretical Impact of Florbetapir ((18)F) Amyloid Imaging on the Diagnosis of Alzheimer’s Dementia and the Detection of Preclinical Cortical Amyloid
In 2012, florbetapir ((18)F) (Amyvid) received US FDA approval as a diagnostic agent for detecting neuritic (β-amyloid) plaques in live patients. Although such approval is specifically not extended to the usage of florbetapir as a single definitive diagnostic test for Alzheimer disease dementia (ADD...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4169306/ https://ncbi.nlm.nih.gov/pubmed/25192053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NEN.0000000000000114 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|